Medicenna Therapeutics Corp. Common Shares

MDNA

...

MDNA: Medicenna Therapeutics Corp is a Canada-based immuno-oncology company. Its principal business activity is the development and commercialization of IL-2, IL-4, and IL13 Superkines and Empowered Superkines for the treatment of cancer and other diseases. Its pipeline candidates include MDNA55 for recurrent glioblastoma multiforme (rGBM), MDNA11 for Cancer immunotherapies, MDNA209 for Autoimmune Diseases, MDNA413 for Cancer immunotherapies, and MDNA132 for Solid Tumors, BiSKITs represents the novel platform comprised of Bifunctional SuperKine ImmunoTherapies.

Show MDNA Financials

All

Government

Consumer Interest

SEC Filings

ESG/Other

Congress Trading

Recent trades of MDNA by members of U.S. Congress

No Congress Trading data for this ticker

Congress Trading Dashboard

Whale Activity

Recently reported changes by institutional investors

No Whale Activity for this ticker

Institutional Holdings Dashboard

Insider Trading

Quarterly net insider trading by MDNA's directors and management

No recent Insider Trading for this ticker

Insider Trading Dashboard

Corporate Lobbying

Government lobbying spending instances

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard

U.S. Patents

New patents grants

No new patents for this ticker

U.S. Patents Dashboard

Government Contracts

Federal grants, loans, and purchases

No Government Contracts for this ticker

Government Contracts Dashboard

Twitter

Followers on MDNA's company Twitter account

WallStreetBets

Number of mentions of MDNA in WallStreetBets Daily Discussion

MDNA News

Recent insights relating to MDNA

CNBC Recommendations

Recent picks made for MDNA stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in MDNA

Corporate Flights

Flights by private jets registered to MDNA